ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1380	National Cancer Institute	Html	en	Colorectal Cancer Prevention (PDQ®)–Health Professional Version	Expert-reviewed information summary about factors that may influence the risk of developing colorectal cancer and about research aimed at the prevention of this disease.	colon cancer death 0.503164 colorectal adenoma chemoprevention 0.469587 mg/day ASA group 0.474963 Engl J Med 0.695761 colorectal cancer risk 0.569497 American Cancer Society 0.478754 cancer prevention study 0.51311 Br J Cancer 0.490702 case-control study 0.528084 CRC mortality rates 0.469166 Ann Intern Med 0.669327 Int J Cancer 0.468816 colorectal cancer 0.947004 fatal colorectal cancer 0.499741 advanced colorectal adenomas 0.4802 colon cancer prevention 0.492834 CRC incidence 0.472239 Natl Cancer Inst 0.758173 human colon cancer 0.480578 hereditary nonpolyposis colorectal 0.489202 distal colon cancer 0.492725 colorectal adenomatous polyps 0.518043 colorectal adenoma prevention 0.476577 long-term cancer incidence 0.468066 familial adenomatous polyposis 0.503867	et al. 0.597227 familial colorectal cancer 0.51297 large bowel cancer 0.489321 colorectal adenomas 0.590599 previous colorectal cancer 0.507755 nonpolyposis colorectal cancer 0.531539 cohort study 0.504026 Cancer Epidemiol Biomarkers 0.584507 hereditary colon cancer 0.485595 fatal colon cancer 0.501384 PUBMED Abstract 0.577579 CRC mortality 0.486759 Health Study 0.488018 National Cancer Institute 0.488273 Epidemiol Biomarkers Prev 0.558059 colorectal cancer incidence 0.562507 colorectal cancer disparities 0.516267 common colorectal cancer 0.511542 colorectal cancer rates 0.517039 colon cancer 0.785918 Abstract 0.678628 colon cancer risk 0.507338 in-trial cancer deaths 0.471053 colorectal cancer mortality 0.563581	CLICK HERE
1394	National Cancer Institute	Html	en	Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pancreatic neuroendocrine tumors (islet cell tumors).	patient selection factors 0.438228 tumor cell types 0.413939 functional tumors 0.556939 slow-growing tumors 0.428195 pituitary tumors 0.418826 functional pancreatic neuroendocrine 0.426256 islet cell tumors 0.811481 preoperative dual-phase thin-section 0.348132 bone metastases 0.398217 islet cell cancers 0.399777 distinctive metabolic effects 0.341484 secondary endocrine tumors 0.452606 liver metastases 0.990586 unresectable liver metastases 0.497768 endocrine pancreas glands 0.386 metastatic disease 0.427564 sporadic islet cell 0.397131 resectable liver metastases 0.506505 venous sampling 0.390094 surgical resection series 0.389796 visible liver metastases 0.615044 liver neuroendocrine metastases 0.512043 individual tumors 0.388972 progressive pancreatic NETs 0.411807 clinical manifestations 0.349816	percutaneous alcohol ablation 0.339566 antihormonal pharmacologic therapy 0.339279 conventional imaging techniques 0.33881 radiofrequency ablation 0.342021 pancreatic resection 0.466639 pancreatic islets 0.36916 ulcer-producing Zollinger-Ellison syndrome 0.354188 somatostatin-receptor scintigraphy 0.356211 slow-growing metastatic islet 0.423125 pancreatic NETs 0.575547 technically demanding tests 0.350314 multiple endocrine neoplasia 0.362304 retrospective case series 0.340498 hormonally functional tumors 0.47568 tumor suppressor gene 0.392672 pancreatic islet cell 0.465855 overall tumor burden 0.363718 grossly visible liver 0.505977 MEN-1 syndrome 0.346786 pancreatic neuroendocrine tumors 0.701933 liver resection 0.37949 arterial stimulation 0.345171 common exocrine adenocarcinomas 0.348715 preoperative localization studies 0.4603	CLICK HERE
1447	National Cancer Institute	Html	null	Unusual Cancers of Childhood Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of unusual cancers of childhood such as cancers of the head and neck, chest, abdomen, reproductive system, skin, and others.			CLICK HERE
1611	National Cancer Institute	Html	en	Late Effects of Treatment for Childhood Cancer (PDQ®)–Health Professional Version	Serious, disabling, and life-threatening chronic health conditions adversely affect the health of aging childhood cancer survivors. Learn about the cardiovascular, cognitive, psychosocial, digestive, endocrine, immune, musculoskeletal, reproductive, and urinary late effects and subsequent neoplasms that contribute to a high burden of morbidity in childhood cancer survivors.	adult cancer survivors 0.344142 childhood leukemia survivors 0.307057 Childhood Cancer Guideline 0.302298 childhood cancer therapy 0.296791 long-term cancer survivors 0.295333 childhood cancer survivors 0.499567 Engl J Med 0.269755 Br J Cancer 0.261959 Cancer Survivor cohort 0.269169 Int J Cancer 0.266011 Ann Intern Med 0.263377 5-year survivors 0.295172 cancer survivors research 0.286942 Radiat Oncol Biol 0.277048 breast cancer surveillance 0.269328 adult survivors 0.315122 Hudson MM 0.309712 young adult cancer 0.340977 British Childhood Cancer 0.326521 Natl Cancer Inst 0.402086 survivor study cohort 0.273371 Clin Cancer Res 0.263669 Irradiated Childhood Cancer 0.298512 childhood cancer 0.912384 cancer survivor study 0.693286	et al. 0.431618 late effects 0.3275 long-term survivors 0.333244 cohort study 0.263432 Cancer Epidemiol Biomarkers 0.265429 pediatric cancer survivors 0.286679 PUBMED Abstract 0.35078 Pediatr Blood Cancer 0.447984 radiation-induced breast cancer 0.26406 breast cancer risk 0.280733 Abstract 0.467444 Clin Oncol 0.515912 breast cancer 0.391476 Oncol Biol Phys 0.278259 childhood cancer survivor 0.771953 Cancer Guideline Harmonization 0.260525 young cancer survivors 0.275759 childhood cancer registry 0.291062 long-term follow-up guidelines 0.273165 Cancer J Clin 0.270171 report 0.265432 childhood cancer treatment 0.287484 oncology group 0.32484 long-term childhood cancer 0.311378	CLICK HERE
1768	National Cancer Institute	Html	es	Perjuicios por fumar cigarrillos y beneficios para la salud al dejar el hábito	Hoja informativa que contiene una lista de algunas de las sustancias del humo de tabaco que causan cáncer y describe los problemas de salud causados por fumar y los beneficios de dejar el hábito.	Neck Cancer Epidemiology 0.422589 Mortality Weekly Report 0.414031 Human Services 0.435201 An emerging health 0.441866 Annual smoking-attributable mortality 0.414117 National Health Interview 0.418634 productivity losses—united states 0.413073 muertes prematuras 0.445781 Disease Control 0.419031 tabaco sustancias 0.451048 emerging health crisis 0.417693 promoting smoking 0.427125 Health Benefits 0.414213 Estados Unidos 0.436732 Health Behavior 0.414461 olor.  fumar kreteks 0.444861 smoking cessation after 0.432247 PubMed Abstract 0.980608 smoking cessation 0.497845 Smokeless Tobacco 0.414167 Second-hand Tobacco Smoke 0.420375 International Journal 0.420012 Smoking as 0.425711 Tobacco Research 0.428882 United States 0.434188	British Medical Journal 0.433726 early stage lung 0.412709 Causa cánceres 0.417577 causa enfermedades 0.437169 ambiente causa 0.426356 tobacco smoking 0.490331 obstructiva crónica 0.447997 tobacco aqueous pH 0.419205 Eissenberg T 0.417223 ambiente causa enfermedades 0.423335 causa inflamación 0.413975 Maziak W 0.417052 Ward KD 0.4175 systematic review 0.417039 muerte prematura 0.420666 Chronic Disease Prevention 0.413895 Andrology Prevention Weeks 0.412666 emerging health risk 0.421288 Cancer Institute 0.452427 leucemia mieloide aguda 0.439669 neck cancer 0.417125 cuánta nicotina 0.415037 Public Health Service 0.416067 New England Journal 0.413417	CLICK HERE
1949	National Cancer Institute	Html	es	Tratamiento del linfoma relacionado con el sida (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma relacionado con el sida.	linfáticos afectados.ampliar linfoma 0.30069 estadio iiis+e 0.227448 células madre 0.561403 estadio iv 0.248805 siguientes elementos 0.21398 sudores nocturnos 0.287643 alto riesgo 0.208757 vía oral 0.208173 historial médico 0.211748 rayos x 0.210669 abdomen).ampliar linfoma 0.262027 estadio ie 0.284505 cáncer.ampliar aspiración 0.213287 líquido cefalorraquídeo 0.384161 punción espinal.Ampliar 0.212727 National Cancer Institute 0.208952 Instituto Nacional 0.215593 estadio iie 0.283482	PDQ Tratamiento 0.219955 segura medicamentos 0.210953 líquido incoloro 0.216453 siguientes biopsias 0.213705 estadio iiie 0.319333 siguientes problemas 0.21343 sistema nervioso central 0.917575 Physician Data Query 0.232209 cabo actividades 0.210804 ósea elabora glóbulos 0.24265 SNC).Ampliar Quimioterapia 0.221029 estadio iiis 0.541053 almacena células 0.232785 células b 0.231648 Estadio IIIE+S 0.227106 siguientes pruebas 0.212565 siguientes estadios 0.212441	CLICK HERE
1959	National Cancer Institute	Html	es	Tratamiento del cáncer de vagina (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de vagina.	parto).ampliar anatomía 0.303951 siguientes procedimientos 0.324612 siguientes aspectos 0.303939 pequeña cantidad 0.302401 estadio ii 0.3299 vía oral 0.301938 historial médico 0.303531 rayos x 0.302933 estadio ivb 0.318379 intensa luz 0.302127 Pap.Ampliar Prueba 0.303248 estadio iva 0.313191 National Cancer Institute 0.301226 realidad células 0.307398 vagina causa efectos 0.315579	sangrado anormal 0.312233 áreas anormales.ampliar examen 0.305435 Instituto Nacional 0.302424 PDQ Tratamiento 0.308282 presente sección 0.301728 Physician Data Query 0.305028 medicamento des 0.324421 prueba pap 0.303798 estadio iii 0.307024 pequeña incisión 0.302169 cuello uterino 0.962189 histerectomía abdominal 0.303006 procedimiento.ampliar ureteroscopía 0.30314 siguientes estadios 0.303001	CLICK HERE
1985	National Cancer Institute	Html	es	Descripción del tratamiento de tumores de encéfalo y de médula espinal infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de tumores de encéfalo infantiles.	espinal infantiles.ampliar punción 0.671368 Organización Mundial 0.330213 células madre 0.838888 efectos secundarios meses 0.514746 siguientes aspectos 0.364078 vía oral 0.337627 encéfalo benignos 0.752955 PDQ Descripción 0.372391 efectos tardíos 0.660507 PDQ correspondiente 0.464116 tumor subtipo 0.432726 PDQ Efectos tardíos 0.450037 cáncer.ampliar aspiración 0.351047 Astrocitoma pilomixoide 0.336263 líquido cefalorraquídeo 0.817195 National Cancer Institute 0.340319 siguientes riesgos 0.328861	Instituto Nacional 0.370517 PDQ Tratamiento 0.975349 riesgo promedio 0.357023 presente sección 0.332468 siguientes signos 0.392336 nuevos tipos 0.34964 siguientes factores 0.362333 sistema nervioso central 0.653419 Physician Data Query 0.447911 gliomas astroblastoma 0.333341 pdq correspondiente tipo 0.412457 alto astrocitoma 0.3322 panel derecho 0.358602 espinal infantiles recién 0.572263 siguientes pruebas 0.390652 siguientes sumarios 0.353304 siguientes trastornos 0.347907	CLICK HERE
2078	National Cancer Institute	Html	es	Tomografía computarizada (TC) y exploraciones para cáncer	Hoja informativa sobre el procedimiento y tecnología de la TC y sus usos para examen de detección, diagnóstico y tratamiento del cáncer. Hoja informativa 5.2s del Instituto Nacional del Cáncer.	imágenes llamada fdg 0.212869 hallazgos anómalos 0.149049 Pediatric Computed Tomography 0.196499 persona promedio 0.156787 Retrieved July 0.224181 rayos x 0.774234 from ct scans 0.197405 ACR Appropriateness Criteria® 0.187415 Patient Safety 0.146744 Low Levels 0.215439 Radiation Risks from 0.30681 radiation dose 0.305638 health care providers 0.311726 Lung Screening Trial 0.175719 risks from 0.542401 Assess Health Risks 0.201898 Retrieved June 0.147049 Exposición Innecesaria 0.154118 Internal Medicine 0.215735 Estados Unidos 0.457591 PubMed Abstract 0.688591 from ct 0.241742 mejores imágenes 0.190153 Cancer Imaging Program 0.180886 SEER Cancer Statistics 0.179794	Reducing Radiation from 0.255009 New Hampshire Avenue 0.163654 radiation risks 0.481539 alto riesgo 0.166125 Drug Administration 0.216737 British Medical Journal 0.160951 retrospective cohort study 0.171194 Mi Historia Médica 0.162596 lifetime attributable risk 0.182458 American College 0.194044 National Cancer Institute 0.177442 Health Risks from 0.371263 baja dosis 0.918737 dosis anual promedio 0.421854 from diagnostic imaging 0.192917 arteriopatía coronaria 0.148972 computed tomography 0.455191 Ionizing Radiation 0.294632 risks from exposure 0.389205 National Research Council 0.163031 pequeños riesgos 0.152571 Colegio Americano 0.296344 Estudio Nacional 0.328775 Sociedad Radiológica 0.211562	CLICK HERE
3551	National Cancer Institute	Html	en	Cancer Statistics	Basic information about cancer statistics in the U.S. and how they are used to understand the impact of cancer on society and to develop strategies that address the challenges that cancer poses.	cancer statistics 0.699332 major impact 0.569457 new screening test 0.610486 United States 0.848591 Asian/Pacific Islander women 0.623563 cancer death rate 0.734611 cancer deaths 0.662668 thyroid cancer 0.618391 SEER program website 0.613262 renal pelvis cancer 0.675159 population-based cancer registries 0.661094 African American men 0.620993 number 0.579668 new cancer cases 0.74726 American Cancer Society 0.655347 pancreatic cancer 0.619919 bladder cancer 0.619451 cancer-related deaths 0.575865 average age 0.568157 individual cancer types 0.652597 North American Association 0.605716 racial/ethnic group 0.570832 cancer care 0.615369 cancer diagnosis 0.664799	breast cancer 0.617639 rectum cancer 0.622513 large groups 0.569141 risk factor 0.614571 U.S. population 0.610565 people 0.571698 statistical trends 0.613522 age-adjusted mortality 0.572947 prostate cancer 0.619132 bronchus cancer 0.62075 Central Cancer Registries 0.654709 cancer survivors 0.603772 cancer mortality 0.652323 policy makers 0.566593 Understanding Cancer Prognosis 0.676403 endometrial cancer 0.620993 cancer 0.951216 new cases 0.679157 cancer incidence 0.694185 cancer death rates 0.665983 SEER Cancer Statistics 0.665479 overall cancer death 0.735155 cancer rates 0.609223	CLICK HERE